» Articles » PMID: 18159231

Inhibition of Chk1 Kills Tetraploid Tumor Cells Through a P53-dependent Pathway

Overview
Journal PLoS One
Date 2007 Dec 27
PMID 18159231
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Tetraploidy constitutes an adaptation to stress and an intermediate step between euploidy and aneuploidy in oncogenesis. Tetraploid cells are particularly resistant against genotoxic stress including radiotherapy and chemotherapy. Here, we designed a strategy to preferentially kill tetraploid tumor cells. Depletion of checkpoint kinase-1 (Chk1) by siRNAs, transfection with dominant-negative Chk1 mutants or pharmacological Chk1 inhibition killed tetraploid colon cancer cells yet had minor effects on their diploid counterparts. Chk1 inhibition abolished the spindle assembly checkpoint and caused premature and abnormal mitoses that led to p53 activation and cell death at a higher frequency in tetraploid than in diploid cells. Similarly, abolition of the spindle checkpoint by knockdown of Bub1, BubR1 or Mad2 induced p53-dependent apoptosis of tetraploid cells. Chk1 inhibition reversed the cisplatin resistance of tetraploid cells in vitro and in vivo, in xenografted human cancers. Chk1 inhibition activated p53-regulated transcripts including Puma/BBC3 in tetraploid but not in diploid tumor cells. Altogether, our results demonstrate that, in tetraploid tumor cells, the inhibition of Chk1 sequentially triggers aberrant mitosis, p53 activation and Puma/BBC3-dependent mitochondrial apoptosis.

Citing Articles

A link between mitotic defects and mitotic catastrophe: detection and cell fate.

Sazonova E, Petrichuk S, Kopeina G, Zhivotovsky B Biol Direct. 2021; 16(1):25.

PMID: 34886882 PMC: 8656038. DOI: 10.1186/s13062-021-00313-7.


GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy.

Ei Z, Choochuay K, Tubsuwan A, Pinkaew D, Suksomtip M, Vinayanuwattikun C Sci Rep. 2021; 11(1):22448.

PMID: 34789798 PMC: 8599848. DOI: 10.1038/s41598-021-01540-8.


Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.

Saleh T, Carpenter V, Bloukh S, Gewirtz D Semin Cancer Biol. 2020; 81:37-47.

PMID: 33358748 PMC: 8214633. DOI: 10.1016/j.semcancer.2020.12.010.


Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells.

Galofre C, Gonul Geyik O, Asensio E, Wangsa D, Hirsch D, Parra C Cancers (Basel). 2020; 12(5).

PMID: 32365785 PMC: 7281619. DOI: 10.3390/cancers12051118.


Prognosis, Biology, and Targeting of Dysregulation in Multiple Myeloma.

Flynt E, Bisht K, Sridharan V, Ortiz M, Towfic F, Thakurta A Cells. 2020; 9(2).

PMID: 31991614 PMC: 7072230. DOI: 10.3390/cells9020287.


References
1.
Asher G, Lotem J, Tsvetkov P, Reiss V, Sachs L, Shaul Y . P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci U S A. 2003; 100(25):15065-70. PMC: 299908. DOI: 10.1073/pnas.2436329100. View

2.
Maley C, Galipeau P, Li X, Sanchez C, Paulson T, Blount P . The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 2004; 64(20):7629-33. DOI: 10.1158/0008-5472.CAN-04-1738. View

3.
Galluzzi L, Zamzami N, de La Motte Rouge T, Lemaire C, Brenner C, Kroemer G . Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis. 2007; 12(5):803-13. DOI: 10.1007/s10495-007-0720-1. View

4.
Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M . A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 2006; 20(19):2687-700. PMC: 1578695. DOI: 10.1101/gad.1447006. View

5.
Sampath D, Cortes J, Estrov Z, Du M, Shi Z, Andreeff M . Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood. 2005; 107(6):2517-24. PMC: 1895741. DOI: 10.1182/blood-2005-08-3351. View